Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07659184
PHASE4

IRONCARE: Iron Treatment in Older Patients With Hip Fractures

Sponsor: University of Aarhus

View on ClinicalTrials.gov

Summary

The aim of this study is to investigate the effects of intravenous (IV) iron therapy compared to alternate-day oral iron treatment and no supplementation in older patients with hip fractures. This study will examine the impact of iron treatment on fatigue, functional decline, fear of falling, cognitive impairment, and quality of life, as well as its effects on iron stores and hemoglobin levels, with the overall goal of improving postoperative rehabilitation. The trial will be conducted on five different hospitals in the Central Region of Denmark (Region Midtjylland).

Official title: IRONCARE: Iron Treatment in Older Patients With Hip Fractures - A Double-blinded Placebo-controlled Randomized Trial

Key Details

Gender

All

Age Range

75 Years - Any

Study Type

INTERVENTIONAL

Enrollment

528

Start Date

2026-10-01

Completion Date

2028-09-30

Last Updated

2026-06-24

Healthy Volunteers

No

Interventions

DRUG

Ferric Derisomaltose

Intravenous Ferric Derisomaltose shortly after surgery and placebo tablets on alternate days for 90 days

DRUG

Oral Iron (Ferrous sulphate)

Oral iron sulfate on alternate days for 90 days and IV placebo once shortly after surgery

DRUG

Placebo IV

100 ml Sodium Chloride (NaCl)

DRUG

Placebo Tablets

Placebo tablets on alternate days for 90 days

Locations (5)

Aarhus Univeristy Hospital

Aarhus N, Denmark

Regional Hospital Gødstrup

Herning, Denmark

Regional Hospital Horsens

Horsens, Denmark

Regional Hospital Randers

Randers, Denmark

Regional Hospital Viborg

Viborg, Denmark